Feature
News from us and our partners
News
News
Capital
News
Biovelocita
News
Crossover
News
Capital
News
In memory of Denis Lucquin, Sofinnova chairman
Sofinnova Partners closes Capital XI at €650M
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
CEO spotlight: Thierry Abribat's third straight win
Johnson & Johnson to acquire Shockwave Medical
CEO spotlight: CinCor's Marc de Garidel
Tags
Topics
0 results
- News
P2 Science raises $23M to expand green chemistry platform
- News
HAYA Therapeutics doses first cohort in Phase 1 trial
- News
Tulyp Medical appoints Steve Motes as CEO
- News
Baxfendy approved in the US for hypertension
- News
Sensorion appoints Fred Chereau as CEO
- News
Hemab Therapeutics closes $347M Nasdaq IPO
- News
CellCentric raises $220M Series D for inobrodib trials
- News
Signadori Bio raises €11M seed to advance tumour platform
- News
Hemab Therapeutics prices IPO at $18 per share
- News
Freya Biosciences reports positive Phase 1 data for FB301
- News
In memory of Denis Lucquin, Sofinnova chairman
- News
Biotalys hits first milestone in Syngenta bioinsecticide deal
- News
Signadori Bio appoints Dr. Selwyn Ho as CEO
- News
Bioptimus launches STELA spatial biology atlas
- News
Abivax reports full year 2025 results